The outgoing surgeon general will have to rely on Congress and the next administration to add warnings about cancer risks to ...

The explosive rise of GLP-1 drugs like Ozempic has brought an accompanying challenge: logistics too knotty for a single ...

The U.S. surgeon general on Friday called for alcoholic beverages to carry labels warning of their connection to cancer, just ...

Trump's staff is laying the groundwork to prepare for a new FDA commissioner and make their mark at the agency.

Snake oil, it turns out, motivated the founding of the FDA. The term “snake oil” arose out of a controversy from the late ...

The alcohol industry relies on the myth of “responsible enjoyment” to downplay its products’ risks while spreading misinformation to stifle regulation.

As a chronic pain patient, I have experienced the anguish and degradation of being denied pain medication firsthand,” a STAT reader writes.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Happy New Year, biotech ...

The updates are fairly straightforward. The government is requiring hospitals to include additional pieces of data to improve ...

Aletha Maybank, who became the American Medical Association’s first chief equity officer five and half years ago, is leaving ...